The impact of clinical pharmacists on drug-related problems and clinical outcomes

Basic and Clinical Pharmacology and Toxicology

Volumn 102, Issue 3, 2008, Pages 275-280

  Viktil, Kirsten K ^a,c   Blix, Hege Salvesen ^b,c  

^a DIAKONHJEMMET HOSPITAL   (Norway)

^b LOVISENBERG DIAKONALE HOSPITAL   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LIPID;

ANTICOAGULATION; BLOOD PRESSURE; CLINICAL PHARMACY; CLINICAL PRACTICE; FOLLOW UP; HEART FAILURE; HOSPITAL READMISSION; HUMAN; LENGTH OF STAY; MORBIDITY; MORTALITY; OUTCOME ASSESSMENT; PATIENT CARE; PATIENT COUNSELING; PHARMACIST; PRESCRIPTION; PRIORITY JOURNAL; QUALITY OF LIFE; SHORT SURVEY; THROMBOEMBOLISM;

DRUG THERAPY; HUMANS; PATIENT CARE TEAM; PHARMACEUTICAL PREPARATIONS; PHARMACEUTICAL SERVICES; PHARMACISTS; PROFESSIONAL ROLE; TREATMENT OUTCOME;

EID: 39649123695     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2007.00206.x     Document Type: Short Survey

References (50)

1. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 1998 279 : 1200 5.
2. Roughead EE, Gilbert AL, Primrose JG, Sansom LN. Drug-related hospital admissions: a review of Australian studies published 1988-1996. Med J Aust 1998 168 : 405 8.
3. Buajordet I, Ebbesen J, Erikssen J, Brørs O, Hilberg T. Fatal adverse drug events: the paradox of drug treatment. J Intern Med 2001 250 : 327 41.
4. Ernst ME, Iyer SS, Doucette WR. Drug-related problems and quality of life in arthritis and low back pain sufferers. Value Health 2003 6 : 51 8.
5. Katon W. Improvement of outcomes in chronic illness. Arch Fam Med 2000 9 : 709 11.
6. van Mil JWF. PCNE Classification for Drug-Related Problems V5.01. http://www.pcne.org/ August 2007.
7. Lagnaoui R, Moore N, Fach J, Longy-Boursier M, Begaud B. Adverse drug reactions in a department of systemic diseases-oriented internal medicine: prevalence, incidence, direct costs and avoidability. Eur J Clin Pharmacol 2000 56 : 181 6.
8. Hallas J. Drug related hospital admissions in subspecialities of internal medicine. Dan Med Bull 1996 43 : 141 55.
9. Gurwitz JH, Field TS, Avorn J et al. Incidence and preventability of adverse drug events in nursing homes. Am J Med 2000 109 : 87 94.
10. O'Dell KM, Kucukarslan SN. Impact of the clinical pharmacist on readmission in patients with acute coronary syndrome. Ann Pharmacother 2005 39 : 1423 7.
11. Kucukarslan SN, Peters M, Mlynarek M, Nafziger DA. Pharmacists on rounding teams reduce preventable adverse drug events in hospital general medicine units. Arch Intern Med 2003 163 : 2014 8.
12. Sorensen L, Stokes JA, Purdie DM, Woodward M, Elliott R, Roberts MS. Medication reviews in the community: results of a randomized, controlled effectiveness trial. Br J Clin Pharmacol 2004 58 : 648 64.
13. Krska J, Cromarty JA, Arris F et al. Pharmacist-led medication review in patients over 65: a randomized, controlled trial in primary care. Age Ageing 2001 30 : 205 11.
14. Sellors J, Kaczorowski J, Sellors C et al. A randomized controlled trial of a pharmacist consultation program for family physicians and their elderly patients. CMAJ 2003 169 : 17 22.
15. Doucette WR, McDonough RP, Klepser D, McCarthy R. Comprehensive medication therapy management: identifying and resolving drug-related issues in a community pharmacy. Clin Ther 2005 27 : 1104 11.
16. Galindo C, Olive M, Lacasa C et al. Pharmaceutical care: pharmacy involvement in prescribing in an acute-care hospital. Pharm World Sci 2003 25 : 56 64.
17. Patel HR, Pruchnicki MC, Hall LE. Assessment for chronic kidney disease service in high-risk patients at community health clinics. Ann Pharmacother 2005 39 : 22 7.
18. Blix HS, Viktil KK, Reikvam A et al. The majority of hospitalised patients have drug-related problems: results from a prospective study in general hospitals. Eur J Clin Pharmacol 2004 60 : 651 8.
19. Buck TC, Brandstrup L, Brandslund I, Kampmann JP. The effects of introducing a clinical pharmacist on orthopaedic wards in Denmark. Pharm World Sci 2007 29 : 12 8.
20. Soendergaard B, Kirkeby B, Dinsen C, Herborg H, Kjellberg J, Staehr P. Drug-related problems in general practice: results from a development project in Denmark. Pharm World Sci 2006 28 : 61 4.
21. Bremberg ER, Hising C, Nylen U, Ehrsson H, Eksborg S. An evaluation of pharmacist contribution to an oncology ward in a Swedish hospital. J Oncol Pharm Pract 2006 12 : 75 81.
22. Spinewine A, Dhillon S, Mallet L, Tulkens PM, Wilmotte L, Swine C. Implementation of ward-based clinical pharmacy services in Belgium: description of the impact on a geriatric unit. Ann Pharmacother 2006 40 : 720 8.
23. Hanlon JT, Weinberger M, Samsa GP et al. A randomized, controlled trial of a clinical pharmacist intervention to improve inappropriate prescribing in elderly outpatients with polypharmacy. Am J Med 1996 100 : 428 37.
24. Hanlon JT, Lindblad CI, Gray SL. Can clinical pharmacy services have a positive impact on drug-related problems and health outcomes in community-based older adults? Am J Geriatr Pharmacother 2004 2 : 3 13.
25. Schmidt IK, Claesson CB, Westerholm B, Nilsson LG. Physician and staff assessments of drug interventions and outcomes in Swedish nursing homes. Ann Pharmacother 1998 32 : 27 32.
26. Blix HS, Viktil KK, Moger TA, Reikvam A. Characteristics of drug-related problems discussed by hospital pharmacists in multidisciplinary teams. Pharm World Sci 2006 28 : 152 8.
27. Viktil KK, Blix HS, Moger TA, Reikvam A. Interview of patients by pharmacists contributes significantly to the identification of drug-related problems (DRPs). Pharmacoepidemiol Drug Saf 2006 15 : 667 74.
28. Lee J, McPherson ML. Outcomes of recommendations by hospice pharmacists. Am J Health Syst Pharm 2006 63 : 2235 9.
29. Patel NP, Brandt CP, Yowler CJ. A prospective study of the impact of a critical care pharmacist assigned as a member of the multidisciplinary burn care team. J Burn Care Res 2006 27 : 310 3.
30. Al-Eidan FA, McElnay JC, Scott MG, McConnell JB. Management of Helicobacter pylori eradication - the influence of structured counselling and follow-up. Br J Clin Pharmacol 2002 53 : 163 71.
31. Weinberger M, Murray MD, Marrero DG et al. Effectiveness of pharmacist care for patients with reactive airways disease: a randomized controlled trial. JAMA 2002 288 : 1594 602.
32. Haynes RB, Yao X, Degani A, Kripalani S, Garg A, McDonald HP. Interventions for enhancing medication adherence. Cochrane Database Syst Rev 2005 4 CD000011. Doi:
33. Dager WE, Branch JM, King JH et al. Optimization of inpatient warfarin therapy: impact of daily consultation by a pharmacist-managed anticoagulation service. Ann Pharmacother 2000 34 : 567 72.
34. Poon IO, Lal L, Brown EN, Braun UK. The impact of pharmacist-managed oral anticoagulation therapy in older veterans. J Clin Pharm Ther 2007 32 : 21 9.
35. Till LT, Voris JC, Horst JB. Assessment of clinical pharmacist management of lipid-lowering therapy in a primary care setting. J Manag Care Pharm 2003 9 : 269 73.
36. Ellis SL, Carter BL, Malone DC et al. Clinical and economic impact of ambulatory care clinical pharmacists in management of dyslipidemia in older adults: the IMPROVE study. Pharmacotherapy 2000 20 : 1508 16.
37. Peterson GM, Fitzmaurice KD, Naunton M, Vial JH, Stewart K, Krum H. Impact of pharmacist-conducted home visits on the outcomes of lipid-lowering drug therapy. J Clin Pharm Ther 2004 29 : 23 30.
38. Reid F, Murray P, Storrie M. Implementation of a pharmacist-led clinic for hypertensive patients in primary care - a pilot study. Pharm World Sci 2005 27 : 202 7.
39. Choe HM, Mitrovich S, Dubay D, Hayward RA, Krein SL, Vijan S. Proactive case management of high-risk patients with type 2 diabetes mellitus by a clinical pharmacist: a randomized controlled trial. Am J Manag Care 2005 11 : 253 60.
40. Gattis WA, Hasselblad V, Whellan DJ, O'Connor CM. Reduction in heart failure events by the addition of a clinical pharmacist to the heart failure management team: results of the pharmacist in heart failure assessment recommendation and monitoring (PHARM) study. Arch Intern Med 1999 159 : 1939 45.
41. Goodyer LI, Miskelly F, Milligan P. Does encouraging good compliance improve patients' clinical condition in heart failure? Br J Clin Pract 1995 49 : 173 6.
42. Dudas V, Bookwalter T, Kerr KM, Pantilat SZ. The impact of follow-up telephone calls to patients after hospitalization. Dis Mon 2002 48 : 239 48.
43. Al-Rashed SA, Wright DJ, Roebuck N, Sunter W, Chrystyn H. The value of inpatient pharmaceutical counselling to elderly patients prior to discharge. Br J Clin Pharmacol 2002 54 : 657 64.
44. Dooley MJ, Allen KM, Doecke CJ et al. A prospective multicentre study of pharmacist initiated changes to drug therapy and patient management in acute care government funded hospitals. Br J Clin Pharmacol 2004 57 : 513 21.
45. Beney J, Bero LA, Bond C. Expanding the roles of outpatient pharmacists: effects on health services utilisation, costs, and patient outcomes. Cochrane Database Syst Rev 2000 2 CD000336. Doi:
46. Kaboli PJ, Hoth AB, McClimon BJ, Schnipper JL. Clinical pharmacists and inpatient medical care: a systematic review. Arch Intern Med 2006 166 : 955 64.
47. Egger T, Dormann H, Ahne G et al. Identification of adverse drug reactions in geriatric inpatients using a computerised drug database. Drugs Aging 2003 20 : 769 76.
48. Magnus D, Rodgers S, Avery AJ. GPs' views on computerized drug interaction alerts: questionnaire survey. J Clin Pharm Ther 2002 27 : 377 82.
49. Schumock GT, Butler MG, Meek PD, Vermeulen LC, Arondekar BV, Bauman JL. Evidence of the economic benefit of clinical pharmacy services: 1996-2000. Pharmacotherapy 2003 23 : 113 32.
50. Bond CA, Raehl CL. Clinical pharmacy services, pharmacy staffing, and adverse drug reactions in United States hospitals. Pharmacotherapy 2006 26 : 735 47.